Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

计划入组 234 人 · 首次发布于 2015 年 8 月 28 日

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

计划入组 120 人 · 首次发布于 2021 年 5 月 18 日

Adjuvant AI Combined With Zoladex

计划入组 670 人 · 首次发布于 2011 年 5 月 11 日

TAM-02

TAM-163

TAM-03

Bullfrog AI

United States

Exscientia AI Ltd.

United Kingdom

Genesis AI Corp

TAM Global Appoints Leading Cancer Immunologist Dr. Francesco Marincola as Chief Scientific Officer

Roche Partner MediLink's B7-H3 ADC Tam-Peli Cuts Death Risk 54% in Relapsed SCLC Phase III

Vietnam Joins Global Effort to Advance Colorectal Cancer Treatment with RBS2418 Clinical Trial